Early-onset Dupilumab Effects in CRSwNP

Stopped Study is no longer interventional. A new observational protocol was created.

Conditions

• Chronic Rhinosinusitis With Nasal Polyps

Interventions

• DRUG: Dupilumab

Sponsor

University of Rochester